MO-PHI-03: TB Treatment and Management

Target Audience

• Medical Officer-PHI

• MO-PHI-03.01: General Concepts in TB Treatment

  • Strategies for TB Treatment
  • Pharmacological Basis of treatment
  • Treatment Phases
  • Fixed Dose Combinations [FDC]s
  • FDCs used in NTEP
  • First line anti TB drugs
  • Second Line anti TB drugs
  • TB Drug Regimen
  • TB Treatment Initiation
  • Pre-treatment Evaluation of TB patients
  • Start Treatment for DSTB patient & DRTB patient
  • Add and view prescription
  • Adding and viewing Patient Notes
  • Long Term Post-treatment follow up of TB patients
  • Reinitiating case
  • Updating and Viewing patient Health Facility details
  • Assigning Patients to ART and DRTB Centres
  • Transferring a patient
  • Transfer of TB Patient Ownership

• MO-PHI-03.02: TB Treatment and Care

  • Drug-Sensitive Tuberculosis [DS-TB]
  • TB Treatment – Steps
  • Treatment Regimen for DSTB – Adult
  • Treatment Regimen for DSTB - Pediatrics
  • Pre-treatment Counselling
  • Pre treatment evaluation of DRTB cases
  • Follow-up of TB patient
  • Regimen, Duration and Dosage for Isoniazid [H] Mono/Poly DR-TB Regimen
  • Isoniazid [H] Mono/Poly DR-TB Regimen: Pre-treatment Evaluation
  • Follow up sputum examination for DR-TB
  • Interim Treatment Outcomes of DR-TB Cases
  • Adverse Drug Reactions [ADRs]
  • ADRs to First Line Treatment
  • Adverse Drug Events: H Mono/Poly DR-TB Regimen
  • TB Treatment Outcome
  • Closing Cases and Assigning Treatment Outcomes
  • Manage TB India Application

• MO-PHI-03.03: Treatment Support

  • Treatment Support Mechanism
  • Treatment Support Plan
  • Treatment supporter [TS] to TB Patient
  • Family Caregiver as a TB Treatment Supporter
  • Roles & responsibilities of Family Care Givers in TB care
  • Registering on Nikshay as Treatment Supporter /Informant
  • Assigning a TS
  • Patient-Provider Meetings
  • Treatment Support Groups
  • Teleconsultation for treatment support

• MO-PHI-03.04: Adherence Management

  • TB Treatment Adherence
  • Importance of Treatment adherence
  • Recording and Monitoring Adherence
  • Digital Adherence Monitoring Technologies
  • Directly Observed Treatment [DOT]
  • Recording Adherence in Treatment card
  • Recording manual doses in Ni-kshay
  • Recording missed doses in Ni-kshay
  • Recording Adherence using TB Arogya Sathi Application
  • Monitoring of Adherence by NTEP Staff
  • Management of Patients with Treatment Interruptions
  • Adherence Register

• MO-PHI-03.05: TB and comorbid conditions

  • TB Co-morbidities & Special Situations
  • HIV testing of individuals with presumed or confirmed TB
  • Co-trimoxazole prophylactic therapy in persons with HIV and TB coinfection
  • Isoniazid Preventive Therapy [IPT] in People Living with HIV [PLHIV]
  • Diabetes among people with TB
  • National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular diseases and Stroke [NPCDCS]
  • Alcoholism among people with TB
  • Tobacco use among people with TB
  • Silicosis in people with TB
  • Cancer in People with TB
  • TB in Pregnant and Lactating Women

• MO-PHI-03.06: Infection Prevention & Control

  • The Need for Infection Prevention and Control [IPC]
  • Standard Precautions for IPC
  • Hand Hygiene
  • Respiratory Hygiene
  • Airborne Infection Control [AIC]
  • Administrative measures for AIC at a Health Facility
  • Ventilation as an AIC Measure
  • IPC Practices Required at a Microscopy Centre
  • Personal Protective Equipment [PPE] Use in TB Lab Settings
  • Color Coding and Type of Container in Biomedical Waste Management
  • Disposing Off Contaminated Material Safely in Microscopy Centre Laboratory Setting
  • Roles of various stakeholders in IPC

• MO-PHI-03.07: TB Preventive Therapy

  • Eligibility for TPT
  • Approaches for TPT implementation
  • Cascade of Care for TPT
  • Testing for TB Infection
  • Counselling for IGRA/TST
  • TB Preventive Therapy
  • Regimen for TPT
  • Contraindications of TPT
  • ADRs due to TPT
  • Screening among Household Contacts of DR-TB Patients
  • Preventive Treatment for Contacts of DR-TB Patients
  • Counselling for TPT
  • Monitoring adherence to TPT
  • Strategies to promote adherence
  • Role of different stakeholders to promote adherence for TPT
  • Management of missed doses in TPT
  • Follow-up Monitoring for individuals taking TPT
  • Treatment outcomes after TPT
  • Monitoring indicators for TPT